CONMED financials
$46.69+0.45%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Quarter | Q2 '26 Jun 30 | Q1 '26 Mar 31 | Q4 '25 Dec 31 | Q3 '25 Sep 30 | Q2 '25 Jun 30 | Q1 '25 Mar 31 | Q4 '24 Dec 31 | Q3 '24 Sep 30 | Q2 '24 Jun 30 | Q1 '24 Mar 31 | Q4 '23 Dec 31 | Q3 '23 Sep 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $343.5M | $317.0M | $373.2M | $337.9M | $342.3M | $321.3M | $345.9M | $316.7M | $332.1M | $312.3M | $327.0M | $304.6M |
| Gross profit | $197.5M | $183.4M | $218.3M | $166.1M | $188.3M | $177.8M | $198.3M | $179.0M | $183.7M | $172.0M | $182.2M | $168.1M |
| Gross margin | 57.5% | 57.9% | 58.5% | 49.2% | 55.0% | 55.3% | 57.3% | 56.5% | 55.3% | 55.1% | 55.7% | 55.2% |
| Operating income | $36.4M | $25.4M | $36.6M | $11.9M | $38.2M | $16.0M | $52.5M | $65.7M | $47.1M | $35.0M | $50.2M | $30.3M |
| Net income | $23.1M | $13.8M | $16.7M | $2.9M | $21.4M | $6.0M | $33.8M | $49.0M | $30.0M | $19.7M | $33.1M | $15.8M |
| Net margin | 6.7% | 4.4% | 4.5% | 0.8% | 6.3% | 1.9% | 9.8% | 15.5% | 9.0% | 6.3% | 10.1% | 5.2% |
| Diluted EPS | $0.77 | $0.45 | $0.53 | $0.09 | $0.69 | $0.19 | $1.09 | $1.57 | $0.96 | $0.63 | $1.05 | $0.50 |
| EBITDA | $55.5M | $44.3M | $55.5M | $30.5M | $56.7M | $34.2M | $70.5M | $83.7M | $64.9M | $53.1M | $50.2M | $48.2M |
| Operating cash flow | $37.1M | $13.5M | $46.3M | $53.7M | $29.1M | $41.5M | $43.3M | $51.2M | $43.3M | $29.1M | $56.4M | $49.9M |
| Free cash flow | $34.2M | $10.6M | $41.2M | $48.5M | $23.4M | $37.8M | $39.3M | $47.8M | $39.7M | $27.1M | $51.5M | $44.5M |
| Diluted shares | 30.1M | 30.6M | 31.3M | 31.1M | 31.1M | 31.2M | 31.1M | 31.1M | 31.1M | 31.3M | 31.5M | 31.7M |
Balance sheet
| Period end | Jun 30 | Mar 31 | Dec 31 | Sep 30 | Jun 30 | Mar 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $37.3M | $35.0M | $40.8M | $38.9M | $33.9M | $35.5M |
| Short-term investments | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total debt | $834.2M | $860.9M | $834.9M | $853.8M | $881.8M | $892.2M |
| Total assets | $2.30B | $2.31B | $2.33B | $2.32B | $2.33B | $2.30B |
| Total liabilities | $1.26B | $1.30B | $1.29B | $1.31B | $1.33B | $1.32B |
| Shareholders' equity | $1.04B | $1.02B | $1.03B | $1.01B | $1.00B | $977.6M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology